{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:18:30Z","timestamp":1795025910966,"version":"4.10.2"},"reference-count":102,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Nocardiosis is an uncommon yet potentially devastating infection. Nocardia tends to affect individuals with chronic lung disease or immunocompromising conditions, 2 groups increasing in number. Incidence of nocardiosis is likely to increase as well, and it is vital to have an approach to this complex disease. Here, we aim to review the presentation, diagnosis, and management of Nocardia in the modern era. We will also highlight areas of uncertainty in our understanding of nocardiosis and propose a general approach to nocardiosis therapy, accounting for response and tolerance of Nocardia treatment.<\/jats:p>","DOI":"10.1093\/cid\/ciae643","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T15:30:28Z","timestamp":1734708628000},"page":"e53-e64","source":"Crossref","is-referenced-by-count":58,"title":["State-of-the-Art Review: Modern Approach to Nocardiosis\u2014Diagnosis, Management, and Uncertainties"],"prefix":"10.1093","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2098-2868","authenticated-orcid":false,"given":"Zachary A","family":"Yetmar","sequence":"first","affiliation":[{"name":"Department of Infectious Disease, Cleveland Clinic Foundation, Cleveland, Ohio ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2433-3232","authenticated-orcid":false,"given":"Paige K","family":"Marty","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Cleveland Clinic Foundation , Cleveland, Ohio ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0400-0978","authenticated-orcid":false,"given":"Josh","family":"Clement","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Mount Sinai Hospital , New York, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1296-9105","authenticated-orcid":false,"given":"Cyndee","family":"Miranda","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Cleveland Clinic Foundation, Cleveland, Ohio ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2853-8219","authenticated-orcid":false,"given":"Nancy L","family":"Wengenack","sequence":"additional","affiliation":[{"name":"Division of Clinical Microbiology, Mayo Clinic, Rochester, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5807-2299","authenticated-orcid":false,"given":"Elena","family":"Beam","sequence":"additional","affiliation":[{"name":"Division of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic , Rochester, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"key":"2025043020355188400_ciae643-B1","doi-asserted-by":"crossref","first-page":"e0002721","DOI":"10.1128\/cmr.00027-21","article-title":"Updated review on Nocardia species: 2006\u20132021","volume":"35","author":"Traxler","year":"2022","journal-title":"Clin Microbiol Rev"},{"key":"2025043020355188400_ciae643-B2","doi-asserted-by":"crossref","first-page":"e2346598","DOI":"10.1001\/jamanetworkopen.2023.46598","article-title":"Global burden of chronic obstructive pulmonary disease through 2050","volume":"6","author":"Boers","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2025043020355188400_ciae643-B3","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/jama.2023.28019","article-title":"Prevalence of immunosuppression among US adults","volume":"331","author":"Martinson","year":"2024","journal-title":"JAMA"},{"key":"2025043020355188400_ciae643-B4","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1469-0691.2010.03306.x","article-title":"Nocardiosis in Quebec, Canada, 1988\u20132008","volume":"17","author":"Tremblay","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"2025043020355188400_ciae643-B5","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/MD.0b013e3181afa1c8","article-title":"Nocardiosis at the turn of the century","volume":"88","author":"Minero","year":"2009","journal-title":"Medicine"},{"key":"2025043020355188400_ciae643-B6","doi-asserted-by":"crossref","first-page":"ofad409","DOI":"10.1093\/ofid\/ofad409","article-title":"Mortality after nocardiosis: risk factors and evaluation of disseminated infection","volume":"10","author":"Yetmar","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2025043020355188400_ciae643-B7","doi-asserted-by":"crossref","first-page":"e0189021","DOI":"10.1128\/aac.01890-21","article-title":"Nocardiosis in Japan: a multicentric retrospective cohort study","volume":"66","author":"Takamatsu","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"2025043020355188400_ciae643-B8","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jinf.2022.05.029","article-title":"Prognosis and factors associated with disseminated nocardiosis: a ten-year multicenter study","volume":"85","author":"Soueges","year":"2022","journal-title":"J Infect"},{"key":"2025043020355188400_ciae643-B9","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1007\/s10875-020-00866-8","article-title":"Nocardiosis associated with primary immunodeficiencies (Nocar-DIP): an international retrospective study and literature review","volume":"40","author":"Lafont","year":"2020","journal-title":"J Clin Immunol"},{"key":"2025043020355188400_ciae643-B10","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.4049\/jimmunol.162.9.5033","article-title":"Cutting edge: protective response to pulmonary injury requires gamma delta T lymphocytes","volume":"162","author":"King","year":"1999","journal-title":"J Immunol"},{"key":"2025043020355188400_ciae643-B11","doi-asserted-by":"crossref","first-page":"818654","DOI":"10.1155\/2013\/818654","article-title":"Clinical characteristics of Nocardia infection in patients with rheumatic diseases","volume":"2013","author":"Yamagata","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"2025043020355188400_ciae643-B12","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1080\/14397595.2020.1823070","article-title":"Clinical features and prognosis of nocardiosis in patients with connective tissue diseases","volume":"31","author":"Yagishita","year":"2021","journal-title":"Mod Rheumatol"},{"key":"2025043020355188400_ciae643-B13","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jinf.2006.08.003","article-title":"Nocardia species infections in a large county hospital in Miami: 6 years experience","volume":"54","author":"Castro","year":"2007","journal-title":"J Infect"},{"key":"2025043020355188400_ciae643-B14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1513\/AnnalsATS.201611-907OC","article-title":"Increasing Nocardia incidence associated with bronchiectasis at a tertiary care center","volume":"14","author":"Woodworth","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"2025043020355188400_ciae643-B15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/thorax-2023-220040","article-title":"Infections in autoimmune pulmonary alveolar proteinosis: a large retrospective cohort","volume":"79","author":"Mabo","year":"2024","journal-title":"Thorax"},{"key":"2025043020355188400_ciae643-B16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jinf.2012.03.020","article-title":"Opportunistic infections in patients with pulmonary alveolar proteinosis","volume":"65","author":"Punatar","year":"2012","journal-title":"J Infect"},{"key":"2025043020355188400_ciae643-B17","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1164\/rccm.202112-2742SO","article-title":"Autoimmune pulmonary alveolar proteinosis","volume":"205","author":"McCarthy","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2025043020355188400_ciae643-B18","doi-asserted-by":"crossref","first-page":"752856","DOI":"10.3389\/fimmu.2021.752856","article-title":"The role of GM-CSF autoantibodies in infection and autoimmune pulmonary alveolar proteinosis: a concise review","volume":"12","author":"Ataya","year":"2021","journal-title":"Front Immunol"},{"key":"2025043020355188400_ciae643-B19","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/cid\/ciu968","article-title":"Nocardia-induced granulocyte macrophage colony-stimulating factor is neutralized by autoantibodies in disseminated\/extrapulmonary nocardiosis","volume":"60","author":"Rosen","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2025043020355188400_ciae643-B20","doi-asserted-by":"crossref","first-page":"ofae269","DOI":"10.1093\/ofid\/ofae269","article-title":"Nocardia infection in patients with anti\u2013granulocyte-macrophage colony-stimulating factor autoantibodies: a prospective multicenter French study","volume":"11","author":"Kerdiles","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"2025043020355188400_ciae643-B21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.diagmicrobio.2013.05.008","article-title":"Cutaneous manifestations of Nocardia brasiliensis infection in Taiwan during 2002\u20132012\u2014clinical studies and molecular typing of pathogen by gyrB and 16S gene sequencing","volume":"77","author":"Chen","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2025043020355188400_ciae643-B22","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/cid\/ciw241","article-title":"Nocardia infection in solid organ transplant recipients: a multicenter European case-control study","volume":"63","author":"Coussement","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2025043020355188400_ciae643-B23","doi-asserted-by":"crossref","first-page":"e12436","DOI":"10.1097\/MD.0000000000012436","article-title":"Manifestations and outcomes of Nocardia infections: comparison of immunocompromised and nonimmunocompromised adult patients","volume":"97","author":"Steinbrink","year":"2018","journal-title":"Medicine"},{"key":"2025043020355188400_ciae643-B24","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jiac.2016.08.004","article-title":"Clinical characteristics of pulmonary nocardiosis in immunocompetent patients","volume":"22","author":"Fujita","year":"2016","journal-title":"J Infect Chemother"},{"key":"2025043020355188400_ciae643-B25","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.3346\/jkms.2024.39.e107","article-title":"Comparative analysis of CT findings and clinical outcomes in adult patients with disseminated and localized pulmonary nocardiosis","volume":"39","author":"Lee","year":"2024","journal-title":"J Korean Med Sci"},{"key":"2025043020355188400_ciae643-B26","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s10096-019-03796-5","article-title":"Nocardia colonization in contrast to nocardiosis: a comparison of patients\u2019 clinical characteristics","volume":"39","author":"Margalit","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2025043020355188400_ciae643-B27","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.clindermatol.2019.10.009","article-title":"Cutaneous nocardiosis: a great imitator","volume":"38","author":"Ramos-e-Silva","year":"2020","journal-title":"Clin Dermatol"},{"key":"2025043020355188400_ciae643-B28","doi-asserted-by":"crossref","first-page":"696","DOI":"10.4269\/ajtmh.22-0300","article-title":"Epidemiological, clinical, and histopathological characteristics of patients with sporotrichoid lymphocutaneous infection in southern Thailand: a 10-year retrospective study","volume":"108","author":"Wongrat","year":"2023","journal-title":"Am J Trop Med Hyg"},{"key":"2025043020355188400_ciae643-B29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11908-019-0684-7","article-title":"Updates on Nocardia skin and soft tissue infections in solid organ transplantation","volume":"21","author":"Hemmersbach-Miller","year":"2019","journal-title":"Curr Infect Dis Rep"},{"key":"2025043020355188400_ciae643-B30","doi-asserted-by":"crossref","first-page":"ofab067","DOI":"10.1093\/ofid\/ofab067","article-title":"Clinical presentation, management, and outcomes of patients with brain abscess due to Nocardia species","volume":"8","author":"Corsini Campioli","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"2025043020355188400_ciae643-B31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MD.0000000000000012","article-title":"Nocardiosis of the central nervous system","volume":"93","author":"Anagnostou","year":"2014","journal-title":"Medicine"},{"key":"2025043020355188400_ciae643-B32","doi-asserted-by":"crossref","first-page":"e200134","DOI":"10.1212\/CPJ.0000000000200134","article-title":"Clinical and radiographic characteristics of Nocardia vs non-Nocardia brain abscesses","volume":"13","author":"LaHue","year":"2023","journal-title":"Neurol Clin Pract"},{"key":"2025043020355188400_ciae643-B33","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/cid\/ciab866","article-title":"Nocardia infections in hematopoietic cell transplant recipients: a multicenter international retrospective study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation","volume":"75","author":"Averbuch","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2025043020355188400_ciae643-B34","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijid.2020.01.011","article-title":"Nocardia bacteremia: a single-center retrospective review and a systematic review of the literature","volume":"92","author":"Williams","year":"2020","journal-title":"Int J Infect Dis"},{"key":"2025043020355188400_ciae643-B35","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.3201\/eid1709.101810","article-title":"Central venous catheter\u2013associated Nocardia bacteremia in cancer patients","volume":"17","author":"Al Akhrass","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"2025043020355188400_ciae643-B36","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1086\/314450","article-title":"Nocardia farcinica sternotomy site infections in patients following open heart surgery","volume":"178","author":"Wenger","year":"1998","journal-title":"J Infect Dis"},{"key":"2025043020355188400_ciae643-B37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0195-6701(80)90029-8","article-title":"Nocardia asteroides infection\u2014a transmissible disease","volume":"1","author":"Houang","year":"1980","journal-title":"J Hosp Infect"},{"key":"2025043020355188400_ciae643-B38","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciaa241","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"71","author":"Daley","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025043020355188400_ciae643-B39","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.mayocpiqo.2022.11.002","article-title":"Invasive nocardiosis versus colonization at a tertiary care center: clinical and radiological characteristics","volume":"7","author":"Dumitrascu","year":"2023","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"2025043020355188400_ciae643-B40","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/TP.0000000000004343","article-title":"Outcomes of nocardiosis and treatment of disseminated infection in solid organ transplant recipients","volume":"107","author":"Yetmar","year":"2023","journal-title":"Transplantation"},{"key":"2025043020355188400_ciae643-B41","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1086\/514340","article-title":"Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study","volume":"44","author":"Peleg","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2025043020355188400_ciae643-B42","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.pulmoe.2022.09.005","article-title":"Coinfection of pulmonary nocardiosis and nontuberculous mycobacterial pulmonary disease in patients without known immunodeficiency","volume":"29","author":"Sun","year":"2023","journal-title":"Pulmonology"},{"key":"2025043020355188400_ciae643-B43","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1128\/JCM.41.4.1447-1453.2003","article-title":"Evaluation of the MicroSeq system for identification of mycobacteria by 16S ribosomal DNA sequencing and its integration into a routine clinical mycobacteriology laboratory","volume":"41","author":"Hall","year":"2003","journal-title":"J Clin Microbiol"},{"key":"2025043020355188400_ciae643-B44","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1128\/JCM.02128-15","article-title":"Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of Mycobacterium species, Nocardia species, and other aerobic Actinomycetes","volume":"54","author":"Buckwalter","year":"2016","journal-title":"J Clin Microbiol"},{"key":"2025043020355188400_ciae643-B45","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1128\/JCM.02942-15","article-title":"Multicenter matrix-assisted laser desorption ionization\u2013time of flight mass spectrometry study for identification of clinically relevant Nocardia spp","volume":"54","author":"Blosser","year":"2016","journal-title":"J Clin Microbiol"},{"key":"2025043020355188400_ciae643-B46","volume-title":"Susceptibility testing of mycobacteria, Nocardia spp., and other aerobic Actinomycetes. CLSI guideline M24","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2018","edition":"3rd ed."},{"key":"2025043020355188400_ciae643-B47","volume-title":"Performance standards for susceptibility testing of mycobacteria, Nocardia spp., and other aerobic actinomycetes. CLSI guideline M62","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2018","edition":"1st ed."},{"key":"2025043020355188400_ciae643-B48","doi-asserted-by":"crossref","first-page":"e00002-18","DOI":"10.1128\/JCM.00002-18","article-title":"Clinical assessment of a Nocardia PCR-based assay for diagnosis of nocardiosis","volume":"56","author":"Rouzaud","year":"2018","journal-title":"J Clin Microbiol"},{"key":"2025043020355188400_ciae643-B49","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1093\/cid\/ciac247","article-title":"Targeted metagenomic sequencing-based approach applied to 2146 tissue and body fluid samples in routine clinical practice","volume":"75","author":"Flurin","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2025043020355188400_ciae643-B50","doi-asserted-by":"crossref","first-page":"e0185522","DOI":"10.1128\/jcm.01855-22","article-title":"Plasma microbial cell-free DNA sequencing from over 15,000 patients identified a broad spectrum of pathogens","volume":"61","author":"Park","year":"2023","journal-title":"J Clin Microbiol"},{"key":"2025043020355188400_ciae643-B51","doi-asserted-by":"crossref","first-page":"894678","DOI":"10.3389\/fcimb.2022.894678","article-title":"Metagenomic next-generation sequencing provides prognostic warning by identifying mixed infections in nocardiosis","volume":"12","author":"Jiao","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"2025043020355188400_ciae643-B52","doi-asserted-by":"crossref","first-page":"e0211989","DOI":"10.1371\/journal.pone.0211989","article-title":"Nocardia polymerase chain reaction (PCR)\u2013based assay performed on bronchoalveolar lavage fluid after lung transplantation: a prospective pilot study","volume":"14","author":"Coussement","year":"2019","journal-title":"PLoS One"},{"key":"2025043020355188400_ciae643-B53","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.diagmicrobio.2014.11.002","article-title":"Cross-reactivity of Nocardia spp. in the fungal (1\u20133)-\u03b2-D-glucan assay performed on cerebral spinal fluid","volume":"81","author":"Koncan","year":"2015","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2025043020355188400_ciae643-B54","doi-asserted-by":"crossref","first-page":"e13991","DOI":"10.1111\/tid.13991","article-title":"1,3-\u03b2-D-glucan testing for nocardiosis in solid organ transplant recipients","volume":"24","author":"Yetmar","year":"2022","journal-title":"Transpl Infect Dis"},{"key":"2025043020355188400_ciae643-B55","doi-asserted-by":"crossref","first-page":"116184","DOI":"10.1016\/j.diagmicrobio.2024.116184","article-title":"(1\u20133)-\u00df-D-glucan for the diagnosis of Nocardia infection in solid organ transplant recipients","volume":"108","author":"Paumier","year":"2024","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2025043020355188400_ciae643-B56","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1227\/00006123-199410000-00007","article-title":"Nocardial brain abscess","volume":"35","author":"Mamelak","year":"1994","journal-title":"Neurosurgery"},{"key":"2025043020355188400_ciae643-B57","doi-asserted-by":"crossref","first-page":"e01868-19","DOI":"10.1128\/AAC.01868-19","article-title":"Retrospective analysis of antimicrobial susceptibility profiles of Nocardia species from a tertiary hospital and reference laboratory, 2011 to 2017","volume":"64","author":"Hamdi","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2025043020355188400_ciae643-B58","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-024-02323-9","article-title":"Trimethoprim-sulfamethoxazole dosing and outcomes of pulmonary nocardiosis [manuscript published online ahead of print 26 June 2024]","author":"Yetmar","year":"2024","journal-title":"Infection"},{"key":"2025043020355188400_ciae643-B59","doi-asserted-by":"crossref","first-page":"e13669","DOI":"10.1111\/tid.13669","article-title":"Trimethoprim\/sulfamethoxazole for nocardiosis in solid organ transplant recipients: real-life data from a multicentre retrospective study","volume":"23","author":"Conan","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"2025043020355188400_ciae643-B60","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1128\/AAC.01531-13","article-title":"Susceptibility profiles of Nocardia isolates based on current taxonomy","volume":"58","author":"Schlaberg","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2025043020355188400_ciae643-B61","first-page":"754","article-title":"Epidemiology and susceptibility to antimicrobial agents of the main Nocardia species in Spain","volume":"72","author":"Valdezate","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2025043020355188400_ciae643-B62","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.cmi.2018.06.013","article-title":"Antibiotic susceptibility testing and species identification of Nocardia isolates: a retrospective analysis of data from a French expert laboratory, 2010\u20132015","volume":"25","author":"Lebeaux","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"2025043020355188400_ciae643-B63","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/cid\/cix124","article-title":"Outcome and treatment of nocardiosis after solid organ transplantation: new insights from a European study","volume":"64","author":"Lebeaux","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2025043020355188400_ciae643-B64","doi-asserted-by":"crossref","first-page":"ofaa112","DOI":"10.1093\/ofid\/ofaa112","article-title":"Low-dose TMP-SMX in the treatment of Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis","volume":"7","author":"Butler-Laporte","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2025043020355188400_ciae643-B65","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/FTD.0000000000000282","article-title":"Relationship of sulfamethoxazole therapeutic drug monitoring to clinical efficacy and toxicity","volume":"38","author":"Ice","year":"2016","journal-title":"Ther Drug Monit"},{"key":"2025043020355188400_ciae643-B66","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.jiac.2022.03.020","article-title":"Long-term use of tedizolid for pulmonary nocardiosis","volume":"28","author":"Chomei","year":"2022","journal-title":"J Infect Chemother"},{"key":"2025043020355188400_ciae643-B67","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1128\/AAC.01102-06","article-title":"In vitro activities of tigecycline and eight other antimicrobials against different Nocardia species identified by molecular methods","volume":"51","author":"Cercenado","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"2025043020355188400_ciae643-B68","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1128\/JCM.00298-16","article-title":"In vitro comparison of ertapenem, meropenem, and imipenem against isolates of rapidly growing mycobacteria and Nocardia by use of broth microdilution and etest","volume":"54","author":"Brown-Elliott","year":"2016","journal-title":"J Clin Microbiol"},{"key":"2025043020355188400_ciae643-B69","doi-asserted-by":"crossref","first-page":"e13509","DOI":"10.1111\/ctr.13509","article-title":"Nocardia infections in solid organ transplantation: guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation","volume":"33","author":"Restrepo","year":"2019","journal-title":"Clin Transplant"},{"key":"2025043020355188400_ciae643-B70","doi-asserted-by":"crossref","first-page":"e0008123","DOI":"10.1371\/journal.pntd.0008123","article-title":"Clinical characteristics and treatment of actinomycetoma in northeast Mexico: a case series","volume":"14","author":"C\u00e1rdenas-de la Garza","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"2025043020355188400_ciae643-B71","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.clindermatol.2011.06.027","article-title":"Actinomycetoma and advances in its treatment","volume":"30","author":"Welsh","year":"2012","journal-title":"Clin Dermatol"},{"key":"2025043020355188400_ciae643-B72","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12348-022-00287-1","article-title":"Nocardia keratitis: amikacin nonsusceptibility, risk factors, and treatment outcomes","volume":"12","author":"Adre","year":"2022","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"2025043020355188400_ciae643-B73","doi-asserted-by":"crossref","first-page":"e1671","DOI":"10.1097\/MD.0000000000001671","article-title":"Nocardia arthritis","volume":"94","author":"Chaussade","year":"2015","journal-title":"Medicine"},{"key":"2025043020355188400_ciae643-B74","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.resinv.2017.11.008","article-title":"Relationship between the duration of trimethoprim\/sulfamethoxazole treatment and the clinical outcome of pulmonary nocardiosis","volume":"56","author":"Tashiro","year":"2018","journal-title":"Respir Investig"},{"key":"2025043020355188400_ciae643-B75","doi-asserted-by":"crossref","first-page":"ofae122","DOI":"10.1093\/ofid\/ofae122","article-title":"Epidemiology, timing, and secondary prophylaxis of recurrent nocardiosis","volume":"11","author":"Yetmar","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"2025043020355188400_ciae643-B76","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1399-3062.2010.00588.x","article-title":"In vitro activity of multiple antibiotic combinations against Nocardia: relationship with a short-term treatment strategy in heart transplant recipients with pulmonary nocardiosis","volume":"13","author":"Tripodi","year":"2011","journal-title":"Transpl Infect Dis"},{"key":"2025043020355188400_ciae643-B77","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neuchi.2021.04.022","article-title":"Nocardia farcinica cerebral abscess: a systematic review of treatment strategies","volume":"68","author":"Beucler","year":"2022","journal-title":"Neurochirurgie"},{"key":"2025043020355188400_ciae643-B78","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1179\/016164103101201076","article-title":"Nocardial cerebral abscess: report of three cases and review of the current neurosurgical management","volume":"25","author":"Valarezo","year":"2003","journal-title":"Neurol Res"},{"key":"2025043020355188400_ciae643-B79","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0090-3019(00)00242-1","article-title":"Nocardia asteroides cerebral abscess in immunocompetent hosts: report of three cases and review of surgical recommendations","volume":"53","author":"Fleetwood","year":"2000","journal-title":"Surg Neurol"},{"key":"2025043020355188400_ciae643-B80","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ajo.2018.09.007","article-title":"Diagnosis, clinical presentations, and outcomes of Nocardia endophthalmitis","volume":"197","author":"Dave","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"2025043020355188400_ciae643-B81","doi-asserted-by":"crossref","first-page":"207","DOI":"10.5194\/jbji-9-207-2024","article-title":"Musculoskeletal infections associated with Nocardia species: a case series","volume":"9","author":"Khodadadi","year":"2024","journal-title":"J Bone Jt Infect"},{"key":"2025043020355188400_ciae643-B82","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-018-0042-3","article-title":"Bronchiectasis","volume":"4","author":"Chalmers","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"2025043020355188400_ciae643-B83","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s12931-024-02903-1","article-title":"Microbiological characteristics of the lower airway in adults with bronchiectasis: a prospective cohort study","volume":"25","author":"Duan","year":"2024","journal-title":"Respir Res"},{"key":"2025043020355188400_ciae643-B84","doi-asserted-by":"crossref","first-page":"1700629","DOI":"10.1183\/13993003.00629-2017","article-title":"European Respiratory Society guidelines for the management of adult bronchiectasis","volume":"50","author":"Polverino","year":"2017","journal-title":"Eur Respir J"},{"key":"2025043020355188400_ciae643-B85","first-page":"CD008351","article-title":"Airway clearance techniques for bronchiectasis","volume":"2015:","author":"Lee","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2025043020355188400_ciae643-B86","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.21037\/jtd-22-410","article-title":"Ancillary treatment of patients with lung disease due to non-tuberculous mycobacteria: a narrative review","volume":"14","author":"Youssefnia","year":"2022","journal-title":"J Thorac Dis"},{"key":"2025043020355188400_ciae643-B87","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1086\/341416","article-title":"Nocardia infection in chronic granulomatous disease","volume":"35","author":"Dorman","year":"2002","journal-title":"Clin Infect Dis"},{"key":"2025043020355188400_ciae643-B88","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1111\/tri.13727","article-title":"Autoantibodies against granulocyte macrophage colony-stimulating factor and Nocardia infection in solid organ transplant recipients","volume":"33","author":"Lebeaux","year":"2020","journal-title":"Transplant International"},{"key":"2025043020355188400_ciae643-B89","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1016\/S1473-3099(20)30920-8","article-title":"Treatment of disseminated nocardiosis: a host\u2013pathogen approach with adjuvant interferon gamma","volume":"21","author":"Derungs","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2025043020355188400_ciae643-B90","doi-asserted-by":"crossref","first-page":"e15016","DOI":"10.1111\/ctr.15016","article-title":"Risk factors and prophylaxis for nocardiosis in solid organ transplant recipients: a nested case-control study","volume":"37","author":"Yetmar","year":"2023","journal-title":"Clin Transplant"},{"key":"2025043020355188400_ciae643-B91","doi-asserted-by":"crossref","first-page":"e13478","DOI":"10.1111\/tid.13478","article-title":"Nocardia prophylaxis, treatment, and outcomes of infection in lung transplant recipients: a matched case-control study","volume":"23","author":"Goodlet","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"2025043020355188400_ciae643-B92","doi-asserted-by":"crossref","first-page":"e14355","DOI":"10.1111\/tid.14355","article-title":"Sulfonamide allergy label and the risk of opportunistic infections in solid organ transplant recipients\u2014a retrospective matched cohort study","volume":"26","author":"Al-Shaikhly","year":"2024","journal-title":"Transpl Infect Dis"},{"key":"2025043020355188400_ciae643-B93","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.cmi.2023.10.008","article-title":"Trimethoprim-sulfamethoxazole significantly reduces the risk of nocardiosis in solid organ transplant recipients: systematic review and individual patient data meta-analysis","volume":"30","author":"Passerini","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"2025043020355188400_ciae643-B94","doi-asserted-by":"crossref","first-page":"206.e1","DOI":"10.1016\/j.jtct.2022.12.004","article-title":"Risk factors and outcomes of nocardiosis in hematopoietic stem cell transplant recipients","volume":"29","author":"Yetmar","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"2025043020355188400_ciae643-B95","doi-asserted-by":"crossref","first-page":"106162","DOI":"10.1016\/j.jinf.2024.106162","article-title":"Risk factors for Nocardia infection among allogeneic hematopoietic cell transplant recipients: a case-control study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation","volume":"88","author":"De Greef","year":"2024","journal-title":"J Infect"},{"key":"2025043020355188400_ciae643-B96","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.bbmt.2018.03.010","article-title":"Increased incidence of nocardial infections in an era of atovaquone prophylaxis in allogeneic hematopoietic stem cell transplant recipients","volume":"24","author":"Molina","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"2025043020355188400_ciae643-B97","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.1016\/j.bbmt.2019.07.018","article-title":"Low-dose cotrimoxazole administered in hematopoietic stem cell transplant recipients as prophylaxis for Pneumocystis jirovecii pneumonia is effective in prevention of infection due to Nocardia","volume":"25","author":"Gkirkas","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"2025043020355188400_ciae643-B98","doi-asserted-by":"crossref","first-page":"195","DOI":"10.12659\/AOT.883901","article-title":"Urinary tract infections in kidney transplant recipients: role of gender, urologic abnormalities, and antimicrobial prophylaxis","volume":"18","author":"Ariza-Heredia","year":"2013","journal-title":"Ann Transplant"},{"key":"2025043020355188400_ciae643-B99","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0002-9343(90)90337-D","article-title":"A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophy","volume":"89","author":"Fox","year":"1990","journal-title":"Am J Med"},{"key":"2025043020355188400_ciae643-B100","doi-asserted-by":"crossref","first-page":"e13461","DOI":"10.1111\/tid.13461","article-title":"Alternative pneumocystis prophylaxis in solid organ transplant recipients at two large transplant centers","volume":"23","author":"Lum","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"2025043020355188400_ciae643-B101","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.3201\/eid2710.210620","article-title":"Nocardiosis in immunocompromised patients on alternative pneumocystis prophylaxis","volume":"27","author":"Puing","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"2025043020355188400_ciae643-B102","doi-asserted-by":"crossref","first-page":"e13753","DOI":"10.1111\/tid.13753","article-title":"Recurrent nocardiosis in solid organ transplant recipients: an evaluation of secondary prophylaxis","volume":"23","author":"Yetmar","year":"2021","journal-title":"Transpl Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/80\/4\/e53\/63036513\/ciae643.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/80\/4\/e53\/63036513\/ciae643.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T20:36:12Z","timestamp":1746045372000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/80\/4\/e53\/8123297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":102,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4,30]]},"published-print":{"date-parts":[[2025,4,30]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciae643","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4,15]]},"published":{"date-parts":[[2025,4,15]]}}}